Article
An improved method to produce clinical scale natural killer cells from human pluripotent stem cells
2019-04-21
Abstract excerpt
Human natural killer (NK) cell-based adoptive anti-cancer immunotherapy has gained intense interest with many clinical trials actively recruiting patients to treat a variety of both hematological malignancies and solid tumors. Most of these trials use primary NK cells isolated either from peripheral blood (PB-NK cells) or umbilical cord blood (UCB-NK cells), though these sources require NK cell collection for each...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- aebd2cec-7f2a-5088-a6ff-4bf84a59c9cc
- DOI
- 10.1101/614792
